Related references
Note: Only part of the references are listed.Discovery and development of the Polo-like kinase inhibitor volasertib in cancer therapy
B. T. Gjertsen et al.
LEUKEMIA (2015)
Cell-Penetrating Peptides: Design, Synthesis, and Applications
Dana Maria Copolovici et al.
ACS NANO (2014)
A phase I study of two dosing schedules of volasertib (BI 6727), an intravenous polo-like kinase inhibitor, in patients with advanced solid malignancies
C-C Lin et al.
BRITISH JOURNAL OF CANCER (2014)
SPARC independent drug delivery and antitumour effects of nab-paclitaxel in genetically engineered mice
Albrecht Neesse et al.
GUT (2014)
Tumour necrosis factor α secretion induces protease activation and acinar cell necrosis in acute experimental pancreatitis in mice
Matthias Sendler et al.
GUT (2013)
Plk1 Phosphorylation of Orc2 and Hbo1 Contributes to Gemcitabine Resistance in Pancreatic Cancer
Bing Song et al.
MOLECULAR CANCER THERAPEUTICS (2013)
A randomised phase II trial of the Polo-like kinase inhibitor BI 2536 in chemo-naive patients with unresectable exocrine adenocarcinoma of the pancreas - a study within the Central European Society Anticancer Drug Research (CESAR) collaborative network
K. Mross et al.
BRITISH JOURNAL OF CANCER (2012)
Disputed Paternity: The Uncertain Ancestry of Pancreatic Ductal Neoplasia
Anirban Maitra et al.
CANCER CELL (2012)
Cell transcytosing poly-arginine coated magnetic nanovector for safe and effective siRNA delivery
Omid Veiseh et al.
BIOMATERIALS (2011)
In vivo imaging of pancreatic tumours and liver metastases using 7 Tesla MRI in a murine orthotopic pancreatic cancer model and a liver metastases model
Ivo L. Partecke et al.
BMC CANCER (2011)
Endosomal escape pathways for delivery of biologicals
Amir K. Varkouhi et al.
JOURNAL OF CONTROLLED RELEASE (2011)
Toxicity modelling of Plk1-targeted therapies in genetically engineered mice and cultured primary mammalian cells
Monika Raab et al.
NATURE COMMUNICATIONS (2011)
Delivery of siRNA Therapeutics: Barriers and Carriers
Jie Wang et al.
AAPS JOURNAL (2010)
Breaking down the barriers: siRNA delivery and endosome escape
Monika Dominska et al.
JOURNAL OF CELL SCIENCE (2010)
Approximating a human cancer
Terry Van Dyke
NATURE MEDICINE (2010)
Pancreatic iron loading predicts cardiac iron loading in thalassemia major
Leila J. Noetzli et al.
BLOOD (2009)
The expression of PLK-1 in cervical carcinoma: a possible target for enhancing chemosensitivity
Yuan Zhang et al.
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH (2009)
Targeted Depletion of Polo-Like Kinase (Plk) 1 Through Lentiviral shRNA or a Small-Molecule Inhibitor Causes Mitotic Catastrophe and Induction of Apoptosis in Human Melanoma Cells
Travis L. Schmit et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2009)
Systemic administration of optimized aptamer-siRNA chimeras promotes regression of PSMA-expressing tumors
Justin P. Dassie et al.
NATURE BIOTECHNOLOGY (2009)
Pathways and mechanisms of endocytic recycling
Barth D. Grant et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2009)
Inhibition of Hedgehog Signaling Enhances Delivery of Chemotherapy in a Mouse Model of Pancreatic Cancer
Kenneth P. Olive et al.
SCIENCE (2009)
Phase I Study of ON 01910.Na, a Novel Modulator of the Polo-Like Kinase 1 Pathway, in Adult Patients With Solid Tumors
Antonio Jimeno et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Proton-sponge coated quantum dots for siRNA delivery and intracellular imaging
Maksym V. Yezhelyev et al.
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY (2008)
Polo-like kinase 1 is involved in invasion through extracellular matrix
Aylin Rizki et al.
CANCER RESEARCH (2007)
In vivo imaging of siRNA delivery and silencing in tumors
Zdravka Medarova et al.
NATURE MEDICINE (2007)
Maximizing mouse cancer models
Kristopher K. Frese et al.
NATURE REVIEWS CANCER (2007)
Cell type-specific delivery of siRNAs with aptamer-siRNA chimeras
James O. McNamara et al.
NATURE BIOTECHNOLOGY (2006)
In vivo imaging of tumor response to therapy using a dual-modality imaging strategy
Z Medarova et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Insights into the kinetics of siRNA-mediated gene silencing from live-cell and live-animal bioluminescent imaging
DW Bartlett et al.
NUCLEIC ACIDS RESEARCH (2006)
Superparamagnetic iron oxide nanoparticle probes for molecular imaging
DLJ Thorek et al.
ANNALS OF BIOMEDICAL ENGINEERING (2006)
Phosphorylation by Cdk1 induces Plk1-mediated vimentin phosphorylation during mitosis
T Yamaguchi et al.
JOURNAL OF CELL BIOLOGY (2005)
Synthesis and surface engineering of iron oxide nanoparticles for biomedical applications
AK Gupta et al.
BIOMATERIALS (2005)
Trp53R172H and KraSG12D cooperate to promote chromosomal instability and widely metastatic pancreatic ductal adenocarcinoma in mice
SR Hingorani et al.
CANCER CELL (2005)
Cytotoxicity suppression and cellular uptake enhancement of surface modified magnetic nanoparticles
AK Gupta et al.
BIOMATERIALS (2005)
Orthotopic models of cancer for preclinical drug evaluation: advantages and disadvantages
MC Bibby
EUROPEAN JOURNAL OF CANCER (2004)
In vivo targeting of underglycosylated MUC-1 tumor antigen using a multimodal imaging probe
A Moore et al.
CANCER RESEARCH (2004)
Visualizing a correlation between siRNA localization, cellular uptake, and RNAi in living cells
YL Chiu et al.
CHEMISTRY & BIOLOGY (2004)
Cancer inhibition in nude mice after systemic application of U6 promoter-driven short hairpin RNAs against PLK1
B Spänkuch et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2004)
Macrophage endocytosis of superparamagnetic iron oxide nanoparticles - Mechanisms and comparison of Ferumoxides and Ferumoxtran-10
I Raynal et al.
INVESTIGATIVE RADIOLOGY (2004)
Increased expression of MUC1 in advanced pancreatic cancer
Y Hinoda et al.
JOURNAL OF GASTROENTEROLOGY (2003)
Regulated portals of entry into the cell
SD Conner et al.
NATURE (2003)
Effect of RNA silencing of polo-like kinase-1 (PLK1) on apoptosis and spindle formation in human cancer cells
B Spänkuch-Schmitt et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2002)
MUC1-specific CTLs are non-functional within a pancreatic tumor microenvironment
P Mukherjee et al.
GLYCOCONJUGATE JOURNAL (2001)